Enrique Santamaria
Pamplona, NC, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 171 publications
Unveiling the post translational modification code in Alzheimer's pathogenesis: crosstalk between phosphorylation and acetylation.
Journal: Expert review of proteomics
Published: July 01, 2026
Synergistic chemosensory decline as a multidimensional biomarker of neurodegeneration: A scoping review of the olfactory-gustatory axis in aging.
Journal: Experimental gerontology
Published: June 21, 2026
Host-Derived Proteomic Profiling of Human and Canine Mammary Tumor Xenografts Identifies Enrichment of Lipid Metabolism-Related Pathways.
Journal: Cell biochemistry and biophysics
Published: June 12, 2026
NRF2 deficit prevents pathologic Tau seeding and spreading in an induced tauopathy mouse model.
Journal: Redox biology
Published: January 11, 2026
Early, sex-dependent and progressive proteomic imbalance in the amygdala during Alzheimer´s disease continuum.
Journal: Biology of sex differences
Published: December 09, 2025
Effects of a short-term multicomponent functional exercise program on the serum proteome: an exploratory study in hospitalized older adults.
Journal: The journals of gerontology. Series A, Biological sciences and medical sciences
Published: November 12, 2025
Effects of a short-term multicomponent functional exercise program on the serum proteome: an exploratory study in hospitalized older adults.
Journal: The journals of gerontology. Series A, Biological sciences and medical sciences
Published: November 12, 2025
Targeted neuronal reprogramming rescues memory and neural synchrony in Alzheimer's disease.
Journal: Molecular biomedicine
Published: October 07, 2025
Olfactory proteomics reveals the capacity of the HDAC1 inhibitor pyroxamide to halt the α-synuclein preformed fibrils-induced damage in nasal epithelial, microglial and dopaminergic neuronal cell lines.
Journal: Brain pathology (Zurich, Switzerland)
Published: October 04, 2025
PD-1/LAG-3 signaling rewires T-cells via MYC inhibition.
Journal: Signal transduction and targeted therapy
Published: September 12, 2025
Last Updated: 09/26/2026